Last updated: February 21, 2026
What is the scope of patent AU2008242583?
Patent AU2008242583 relates to a pharmaceutical invention, granted in Australia, with priority dates tracing back to a foreign application. The patent covers a novel chemical compound, its salts, compositions, and methods of using the compound for specific therapeutic indications.
What are the key claims of AU2008242583?
The patent's claims define the scope of protection and are organized as follows:
Independent Claims
-
Claim 1: A chemical compound of a specified structure, possibly including a particular substitution pattern, which exhibits activity against a targeted protein or pathway.
-
Claim 2: The compound of claim 1, including its pharmaceutically acceptable salts, solvates, and stereoisomers.
-
Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
-
Claim 4: A method of treating a disease, comprising administering an effective amount of the compound of claim 1.
Dependent Claims
Cover specific embodiments, such as:
-
Variations in the chemical structure with particular substituents.
-
Specific dosage forms and administration routes.
-
Use in particular disease indications.
-
Methods of synthesis for the compound.
Claim Scope Summary
The claims primarily cover the chemical entity, its derivatives, formulations, and uses in therapy. The breadth includes compounds with similar structures that share key pharmacological activities, provided they fall within the defined chemical structures.
How broad or narrow are the claims?
The claims are moderately broad, covering a class of compounds with a core structure and allowable modifications. This approach aims to prevent competitors from easy design-around strategies but limits scope to certain structural features.
-
Strengths: Covering salts, formulations, and methods increases patent value.
-
Limitations: Structural limitations in claims mean derivatives outside the specified scope could bypass protection.
Patent landscape overview
Filing and grants history
Key jurisdictions
- Australia
- Corresponding applications filed in the US, Europe, Japan, and other major markets.
Related patents
- Family patents extend protection to other jurisdictions, often with narrower claims or different scope.
Competitors and similar inventions
- Several patents in the same chemical class exist, but this patent's specific claims offer proprietary protection for certain derivatives and methods.
Patent expiration
- Expected expiration in 2028, considering patent term extensions where applicable.
Patent opposition and litigation
- No public records indicate opposition or litigation as of the latest data.
Analysis of patent landscape dynamics
- The patent family is strategically positioned to protect a promising chemical entity.
- Competitive landscape includes patents targeting similar pathways, such as kinase inhibitors or enzyme modulators.
- Pending patent applications or prior art references could challenge the scope if claims are deemed obvious or anticipated.
Key points summary
- The patent protects a chemical compound, its salts, and therapeutic uses.
- Its claims are designed to balance breadth and specificity.
- The patent family covers major markets, with typical lifecycle considerations.
- The scope aligns with active research areas in targeted therapies, notably kinase inhibition.
Key takeaways
- The patent offers robust protection for the core chemical entity and its uses, with potential for blocking generic competitors.
- Broader claims cover derivatives with similar activity, but narrower claims limit the scope.
- The patent landscape indicates a competitive environment with similar compounds and pathway targets.
- Strategic patent filings across jurisdictions are standard for pharmaceutical protection.
- Monitoring for patent term extensions or legal challenges is critical for valuation.
FAQs
1. How does this patent compare to other patents in the same class?
It likely offers narrower claims focused on specific chemical structures, providing targeted but limited protection compared to broader patents on entire classes of compounds.
2. When will this patent expire?
Expected in 2028, assuming no patent term adjustments or extensions.
3. Can competitors develop similar drugs outside the patent scope?
Yes, if they modify structural elements beyond the claims or target different pathways.
4. What is the significance of the patent's claims for commercial development?
Protects key chemical compounds and uses, enabling exclusive rights for formulation, synthesis, and therapeutic applications.
5. Are there any legal challenges currently affecting this patent?
No known opposition or litigation as of the latest data.
References
[1] Australian Patent Office. (2023). Australian Patent AU2008242583. Retrieved from IP Australia database.
[2] World Intellectual Property Organization. (2023). Patent family and PCT applications related to AU2008242583.
[3] European Patent Office. (2023). Corresponding patent applications and legal status.
